Objectives: The purpose of this study is investigate the effects of variants in the
apolipoprotein (a) gene (LPA) on vascular diseases with different atherosclerotic and …

Objective—Increased levels of lipoprotein (a) are a highly heritable risk factor for coronary
artery disease (CAD). The genetic determinants of lipoprotein (a) levels are mainly because …

Two independent single-nucleotide polymorphisms (SNPs) in the gene encoding
apolipoprotein (a)(LPA) have been shown to be associated with coronary heart disease …

Background—Genetic studies have identified 2 single-nucleotide polymorphisms (SNPs) at
the LPA locus (rs3798220 and rs10455872) that are strongly and independently related to …

Objectives—The purpose of this study was to identify genetic variants associated with
severe coronary artery disease (CAD). Methods and Results—We used 3 case-control …

OBJECTIVE: A minor allele variant (rs3798220) of apolipoprotein (a) has been reported to
be associated with elevated plasma lipoprotein (a)[Lp (a)] and increased cardiovascular risk …

Background: Genomic analyses have suggested that the LPA gene and its associated
plasma biomarker, lipoprotein (a)(Lp [a]), represent a causal risk factor for coronary heart …

Abstract Background Lipoprotein (a)(Lp [a]) is a causal genetic risk factor for atherosclerotic
cardiovascular disease (ASCVD). There are limited long-term follow-up data from large US …

Objectives: The purpose of this study was to assess the association of apolipoprotein
(a)(apo [a]) isoforms with cardiovascular disease risk. Background: Although circulating …

In 2010, more than 45 years after the initial discovery of lipoprotein (a)[Lp (a)] by Kare Berg,
an European Atherosclerosis Society Consensus Panel recommended screening for …